Patents Assigned to Novassay SA
  • Publication number: 20150212068
    Abstract: Fluorescent bile salt derivatives such as cholyl-L-lysyl-fluorescein have shown diagnostic potential to evaluate biliary elimination. The invention relates to the development of a novel competitive Enzyme-linked immunosorbent assay (ELISA) assay to quantify fluorescent bile salt derivatives for the evaluation of drug-drug interactions and for diagnostic applications.
    Type: Application
    Filed: August 20, 2013
    Publication date: July 30, 2015
    Applicant: Novassay SA
    Inventor: Marc Jonathan Kearsey